Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
---|---|---|---|---|
6/30/2025 | $ 232.84M | 1 | 40.61M | $ 5.73 |
3/31/2025 | $ 214.71M | 1 | 40.56M | $ 5.29 |
12/31/2024 | $ 3.55M | 1 | 37.44M | $ 0.09 |
9/30/2024 | $ 651K | 1 | 37.59M | $ 0.02 |
6/30/2024 | $ 271K | 1 | 36.1M | $ 0.01 |
3/31/2024 | $ 234K | 1 | 35.69M | $ 0.01 |
12/31/2023 | $ 151K | 1 | 29.45M | $ 0.01 |
9/30/2023 | $ 8K | 1 | 29.67M | $ 0 |
6/30/2023 | $ 0 | 1 | 29.6M | $ 0 |
3/31/2023 | $ 0 | 1 | 28.37M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues / (Shares WA * Share Factor)
(=) SPS
SPS for KEROS THERAPEUTICS INC is calculated as follows: Revenues [ $ 0 ] / (Shares WA [ 20.18M ] * Share Factor [ 1 ])
(=) SPS [ $ 0 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.64K |
---|---|
min | $ -18.02 |
max | $ 54.75 |
average | $ 11.53 |
median | $ 5.88 |
std | $ 13.59 |